Developer docs
API playgroundTry for free, no card

Search company profiles

European Respiratory Society

Full company profile

uuid000jucm

Namestring
European Respiratory Society
Legal namestring
European Respiratory Society
Websiteurl
ersnet.org
Company typeenum
Private
Founded yearint
1990
Descriptiontext

The European Respiratory Society (ERS), headquartered in Lausanne, Switzerland, is a nonprofit professional medical society founded in 1990 that serves more than 35,000 clinicians, scientists and allied health professionals in over 160 countries. Its mission centres on alleviating suffering from respiratory disease and promoting lung health through research, education, standard-setting and policy advocacy. ERS operates the world's largest annual respiratory congress (scheduled for 5–9 September 2026 in Barcelona) and runs the European Respiratory Journal, HERMES competency examinations, a fellowship and grants programme, and a portfolio of guidelines, statements and technical standards covering airway disease, interstitial lung disease, thoracic oncology, sleep and breathing disorders, paediatric respiratory diseases and respiratory infections.

The society's technology footprint is built around the ERS Respiratory Channel (a video, podcast and webinar platform), the myERS member portal, an online course management system, and an AI-powered translation layer on webinars supporting up to 60 languages. ERS generates revenue principally through membership subscriptions, Congress and event registration, HERMES certification fees, sponsored educational programmes and webinar charges (free for members, €10 per session for non-members), supplemented by EU and industry grants such as the €185 million, 7-year UNITE4TB tuberculosis consortium. Its go-to-market is event-driven: the annual Congress anchors member acquisition and retention, while year-round webinars, courses and the Respiratory Channel sustain engagement. The society's 2025 strategic review codified five priorities — primary prevention, global collaboration, digital transformation, patient partnerships and sustainability — explicitly signalling an organisational pivot toward digital delivery and cross-society collaboration.

Short descriptiontext

European Respiratory Society is a Lausanne-based nonprofit medical society serving 35,000-plus respiratory clinicians, scientists and allied health professionals in 160+ countries through the world's largest annual respiratory congress, peer-reviewed guidelines, HERMES certification and the ERS Respiratory Channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLausanne, Switzerland
HQ citystring
Lausanne
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
respiratory medicine, clinical practice guidelines, medical congress, professional certification, medical education
NAICS code1 code
  • Business Associations813910
SIC code2 codes
  • Services-Health Services8000
  • Services-Membership Organizations8600
Product category
Professional Medical Society Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Membership Fees
TypeSubscription Recurring
Description

ERS generates revenue through annual membership fees from its over 35,000 members including clinicians, scientists, and allied health professionals.

ersnet.org
2Congress and Event Registration
TypeTransaction Fee
Description

Revenue from registration fees for the annual ERS Congress and other conferences, courses, and webinars.

ersnet.org
3Webinar Fees for Non-Members
TypeTransaction Fee
Description

Some webinars are free for members but charged at €10 for non-members.

channel.ersnet.org
4Educational Programs
TypeSubscription Recurring
Description

Revenue from certified training programmes, HERMES examinations, and other professional development offerings.

ersnet.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Pricing details3 tiers
1Webinar attendance - Member rate
ModelSubscriptionBilling cadencePer session
Notes

Free for ERS members

channel.ersnet.org
2Webinar attendance - Non-member rate
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€10 per session for non-members

channel.ersnet.org
3myERS Account
ModelFreemiumBilling cadenceMonthly
Notes

Free account creation allows access to services, event registration, abstract submission, and newsletters

identity.ersnet.org
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ERS is a professional medical society that delivers education, research dissemination, clinical guidelines, certification, and advocacy services to the global respiratory medicine community. Its core offerings include the annual ERS Congress, the ERS Respiratory Channel for online educational content, HERMES examinations for certification, clinical practice guidelines, peer-reviewed journals, fellowships, webinars, and training programmes, sold primarily through membership and event registration fees.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 35,000 members from 160+ countries served
+2 more records
Product overview1 text field

European Respiratory Society (ERS) operates as a professional medical society offering a comprehensive portfolio of products and services for the respiratory medicine community. The organization provides a multi-platform approach comprising the annual ERS Congress as its flagship event, the ERS Respiratory Channel for online educational content delivery, ERS Guidelines for clinical practice standards, myERS as the membership portal, HERMES Examinations for professional certification, ERS Publications including the European Respiratory Journal, educational webinars with AI-powered translation, scientific workshops and courses, fellowship programmes, and advocacy initiatives. These offerings work together to serve the respiratory professional community through education, research dissemination, certification, and policy advocacy.

Product and service1 record
1ERS Congress
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

In partnership with ERS, the European Lung Foundation (ELF) brings patients and the public together with healthcare professionals to improve lung health and advance diagnosis, treatment and care. This is a core partnership reflecting ERS-ELF joint commitment to strengthening patient-professional partnership in respiratory care and research.

2Forum of International Respiratory Societies (FIRS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ERS participates in FIRS - United for Lung Health, a global coalition of respiratory societies working together to improve lung health worldwide.

ersnet.org
3Conference of European Respiratory Societies (CERS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CERS is a partner society of ERS, representing a collaborative network of European respiratory organizations.

ersnet.org
4UNITE4TB Consortium
Strategic tierMajorTypeStrategic or Co-development Partner
Description

UNITE4TB is a public-private partnership with representation from academic institutions, SMEs, public organisations, and pharmaceutical companies. The 7-year, €185 million project aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs for TB treatment. ERS is co-developing educational content as part of this initiative (ERS/UNITE4TB webinars).

channel.ersnet.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

ERS and ATS collaborate on joint guidelines, such as the guidelines for the diagnosis of Primary Ciliary Dyskinesia.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Joint guideline development on fitness for curative intent treatment of lung cancer.

7European Society for Radiotherapy & Oncology (ESTRO)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration on guidelines such as endobronchial and oesophageal endosonography for diagnosis and staging of lung cancer.

ersnet.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration on endosonography guidelines for lung cancer diagnosis and staging.

9European Alliance of Associations for Rheumatology (EULAR)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Joint clinical practice guidelines for connective tissue disease-associated interstitial lung disease.

ersnet.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Joint statement on treatment of central sleep apnoea with adaptive servo-ventilation.

11International Respiratory Coalition
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ERS advocacy initiative bringing together stakeholders to advocate for respiratory health policy.

ersnet.org
12Latin American Thoracic Association (ALAT)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaborative work on ILD registries and respiratory health around the globe theme.

ersnet.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaborative work on ILD phenotypes and registries as part of global respiratory health initiatives.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CHEST operates the annual CHEST Congress, board certification review courses, peer-reviewed journals, and clinical guidelines in pulmonary, critical care, and sleep medicine — a direct functional peer to ERS across congress, education, and publication.

TypeDirect peer
Description

ATS is the leading US-based respiratory professional society running the ATS International Conference, publishing peer-reviewed journals, and developing clinical guidelines — the most direct global peer to ERS, with whom it already co-develops joint guidelines (e.g., Primary Ciliary Dyskinesia).

3International Union Against Tuberculosis and Lung Disease (The Union)
TypeEmerging player
Description

The Union is an international NGO focused on tuberculosis and lung disease, running the Union World Conference, journals, and training; it overlaps with ERS on respiratory/TB education, journals, and global health advocacy, making it a thematic regional/functional peer.

TypeDirect peer
Description

BTS is a national respiratory professional society running the BTS Winter Meeting, producing clinical guidelines and continuing medical education for UK clinicians, occupying the same membership, education, and guideline niche as ERS at a country level.

TypeBroad incumbent
Description

ESMO runs a similar European society operating model to ERS — annual congress, peer-reviewed journals, clinical guidelines, fellowships, and certified educational programmes — but in oncology, making it a structural comparable for operations and revenue mix.

TypeBroad incumbent
Description

ESC operates a large European medical society model with annual congress, the European Heart Journal, comprehensive clinical guidelines, certified education, and EU policy advocacy — structurally analogous to ERS but in cardiology, illustrating the established broader professional-society playbook.

TypeOthers
Description

ELF is the patient-facing foundation co-located with ERS that amplifies respiratory advocacy, patient-public partnerships, and educational outreach — not a competitor but a closely linked distribution and patient-engagement arm of the ERS ecosystem.

TypeEmerging player
Description

ESRS is a smaller European specialty society focusing on sleep research and medicine, producing joint statements (e.g., with ERS on central sleep apnoea) and serving an overlapping allied-health segment — a thematic peer addressing adjacent clinical content.

9Latin American Thoracic Association (ALAT)
TypeDirect peer
Description

ALAT is the regional respiratory professional society serving Latin America, operating congress, education, and guideline activities; it is a regional peer partner already collaborating with ERS on global respiratory health initiatives.

TypeDirect peer
Description

APSR is the regional respiratory professional society for Asia-Pacific, running congresses, fellowships and joint research initiatives; it is a peer society already partnered with ERS on ILD registries and phenotype research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

European Respiratory Society

Professional Medical Society Servicesersnet.org

European Respiratory Society is a Lausanne-based nonprofit medical society serving 35,000-plus respiratory clinicians, scientists and allied health professionals in 160+ countries through the world's largest annual respiratory congress, peer-reviewed guidelines, HERMES certification and the ERS Respiratory Channel.

What European Respiratory Society does

The European Respiratory Society (ERS), headquartered in Lausanne, Switzerland, is a nonprofit professional medical society founded in 1990 that serves more than 35,000 clinicians, scientists and allied health professionals in over 160 countries. Its mission centres on alleviating suffering from respiratory disease and promoting lung health through research, education, standard-setting and policy advocacy. ERS operates the world's largest annual respiratory congress (scheduled for 5–9 September 2026 in Barcelona) and runs the European Respiratory Journal, HERMES competency examinations, a fellowship and grants programme, and a portfolio of guidelines, statements and technical standards covering airway disease, interstitial lung disease, thoracic oncology, sleep and breathing disorders, paediatric respiratory diseases and respiratory infections.

The society's technology footprint is built around the ERS Respiratory Channel (a video, podcast and webinar platform), the myERS member portal, an online course management system, and an AI-powered translation layer on webinars supporting up to 60 languages. ERS generates revenue principally through membership subscriptions, Congress and event registration, HERMES certification fees, sponsored educational programmes and webinar charges (free for members, €10 per session for non-members), supplemented by EU and industry grants such as the €185 million, 7-year UNITE4TB tuberculosis consortium. Its go-to-market is event-driven: the annual Congress anchors member acquisition and retention, while year-round webinars, courses and the Respiratory Channel sustain engagement. The society's 2025 strategic review codified five priorities — primary prevention, global collaboration, digital transformation, patient partnerships and sustainability — explicitly signalling an organisational pivot toward digital delivery and cross-society collaboration.

European Respiratory Society firmographics

Firmographics
Name
European Respiratory Society
Legal name
European Respiratory Society
Website
https://ersnet.org
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
11–50 employees
Short description
European Respiratory Society is a Lausanne-based nonprofit medical society serving 35,000-plus respiratory clinicians, scientists and allied health professionals in 160+ countries through the world's largest annual respiratory congress, peer-reviewed guidelines, HERMES certification and the ERS Respiratory Channel.
Ownership category
akta.pro rank

Where European Respiratory Society is headquartered

Location

Headquarters

HQ city
Lausanne
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

European Respiratory Society business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

  1. Membership Fees: ERS generates revenue through annual membership fees from its over 35,000 members including clinicians, scientists, and allied health professionals.
  2. Congress and Event Registration: Revenue from registration fees for the annual ERS Congress and other conferences, courses, and webinars.
  3. Webinar Fees for Non-Members: Some webinars are free for members but charged at €10 for non-members.
  4. Educational Programs: Revenue from certified training programmes, HERMES examinations, and other professional development offerings.

Pricing tiers

ModelBillingPrice
SubscriptionPer sessionWebinar attendance - Member rate
One time/ perpetual licensePay-as-you-goWebinar attendance - Non-member rate
FreemiumMonthlymyERS Account

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

European Respiratory Society product offering

Product offering

Core offering

ERS is a professional medical society that delivers education, research dissemination, clinical guidelines, certification, and advocacy services to the global respiratory medicine community. Its core offerings include the annual ERS Congress, the ERS Respiratory Channel for online educational content, HERMES examinations for certification, clinical practice guidelines, peer-reviewed journals, fellowships, webinars, and training programmes, sold primarily through membership and event registration fees.

Product overview

European Respiratory Society (ERS) operates as a professional medical society offering a comprehensive portfolio of products and services for the respiratory medicine community. The organization provides a multi-platform approach comprising the annual ERS Congress as its flagship event, the ERS Respiratory Channel for online educational content delivery, ERS Guidelines for clinical practice standards, myERS as the membership portal, HERMES Examinations for professional certification, ERS Publications including the European Respiratory Journal, educational webinars with AI-powered translation, scientific workshops and courses, fellowship programmes, and advocacy initiatives. These offerings work together to serve the respiratory professional community through education, research dissemination, certification, and policy advocacy.

Differentiator

Problem solved

Functional benefit

Products and services

  • ERS Congress

Quantifiable outcome

  • Over 35,000 members from 160+ countries served
  • +2 more outcomes

Companies that use European Respiratory Society

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles4 records

European Respiratory Society technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability2 records

Feature3 records

European Respiratory Society partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and major.

  • European Lung Foundation (ELF)coreStrategic or Co-development PartnerIn partnership with ERS, the European Lung Foundation (ELF) brings patients and the public together with healthcare professionals to improve lung health and advance diagnosis, treatment and care. This is a core partnership reflecting ERS-ELF joint commitment to strengthening patient-professional partnership in respiratory care and research.
  • Forum of International Respiratory Societies (FIRS)coreStrategic or Co-development PartnerERS participates in FIRS - United for Lung Health, a global coalition of respiratory societies working together to improve lung health worldwide.
  • Conference of European Respiratory Societies (CERS)coreStrategic or Co-development PartnerCERS is a partner society of ERS, representing a collaborative network of European respiratory organizations.
  • UNITE4TB ConsortiummajorStrategic or Co-development PartnerUNITE4TB is a public-private partnership with representation from academic institutions, SMEs, public organisations, and pharmaceutical companies. The 7-year, €185 million project aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs for TB treatment. ERS is co-developing educational content as part of this initiative (ERS/UNITE4TB webinars).
  • American Thoracic Society (ATS)majorStrategic or Co-development PartnerERS and ATS collaborate on joint guidelines, such as the guidelines for the diagnosis of Primary Ciliary Dyskinesia.
  • European Society of Thoracic Surgeons (ESTS)majorStrategic or Co-development PartnerJoint guideline development on fitness for curative intent treatment of lung cancer.
  • European Society for Radiotherapy & Oncology (ESTRO)majorStrategic or Co-development PartnerCollaboration on guidelines such as endobronchial and oesophageal endosonography for diagnosis and staging of lung cancer.
  • European Society of Gastrointestinal and Abdominal Radiology (ESGE)majorStrategic or Co-development PartnerCollaboration on endosonography guidelines for lung cancer diagnosis and staging.
  • European Alliance of Associations for Rheumatology (EULAR)majorStrategic or Co-development PartnerJoint clinical practice guidelines for connective tissue disease-associated interstitial lung disease.
  • European Sleep Research Society (ESRS)majorStrategic or Co-development PartnerJoint statement on treatment of central sleep apnoea with adaptive servo-ventilation.
  • International Respiratory CoalitioncoreStrategic or Co-development PartnerERS advocacy initiative bringing together stakeholders to advocate for respiratory health policy.
  • Latin American Thoracic Association (ALAT)majorStrategic or Co-development PartnerCollaborative work on ILD registries and respiratory health around the globe theme.
  • Asian Pacific Society of Respirology (APSR)majorStrategic or Co-development PartnerCollaborative work on ILD phenotypes and registries as part of global respiratory health initiatives.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

European Respiratory Society competitors and assessment

Company assessment

Direct peers

  • American College of Chest Physicians (CHEST): CHEST operates the annual CHEST Congress, board certification review courses, peer-reviewed journals, and clinical guidelines in pulmonary, critical care, and sleep medicine — a direct functional peer to ERS across congress, education, and publication.
  • American Thoracic Society (ATS): ATS is the leading US-based respiratory professional society running the ATS International Conference, publishing peer-reviewed journals, and developing clinical guidelines — the most direct global peer to ERS, with whom it already co-develops joint guidelines (e.g., Primary Ciliary Dyskinesia).
  • British Thoracic Society (BTS): BTS is a national respiratory professional society running the BTS Winter Meeting, producing clinical guidelines and continuing medical education for UK clinicians, occupying the same membership, education, and guideline niche as ERS at a country level.
  • Latin American Thoracic Association (ALAT): ALAT is the regional respiratory professional society serving Latin America, operating congress, education, and guideline activities; it is a regional peer partner already collaborating with ERS on global respiratory health initiatives.
  • Asian Pacific Society of Respirology (APSR): APSR is the regional respiratory professional society for Asia-Pacific, running congresses, fellowships and joint research initiatives; it is a peer society already partnered with ERS on ILD registries and phenotype research.

Emerging players

  • International Union Against Tuberculosis and Lung Disease (The Union): The Union is an international NGO focused on tuberculosis and lung disease, running the Union World Conference, journals, and training; it overlaps with ERS on respiratory/TB education, journals, and global health advocacy, making it a thematic regional/functional peer.
  • European Sleep Research Society (ESRS): ESRS is a smaller European specialty society focusing on sleep research and medicine, producing joint statements (e.g., with ERS on central sleep apnoea) and serving an overlapping allied-health segment — a thematic peer addressing adjacent clinical content.

Broad incumbents

  • European Society for Medical Oncology (ESMO): ESMO runs a similar European society operating model to ERS — annual congress, peer-reviewed journals, clinical guidelines, fellowships, and certified educational programmes — but in oncology, making it a structural comparable for operations and revenue mix.
  • European Society of Cardiology (ESC): ESC operates a large European medical society model with annual congress, the European Heart Journal, comprehensive clinical guidelines, certified education, and EU policy advocacy — structurally analogous to ERS but in cardiology, illustrating the established broader professional-society playbook.

Others

  • European Lung Foundation (ELF): ELF is the patient-facing foundation co-located with ERS that amplifies respiratory advocacy, patient-public partnerships, and educational outreach — not a competitor but a closely linked distribution and patient-engagement arm of the ERS ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

European Respiratory Society social profiles

Digital presence

European Respiratory Society financial estimates

Financial estimate

Revenue estimate

Valuation estimate

European Respiratory Society leadership team

Management profile

Number of profiles

Profiles4 records

European Respiratory Society funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

European Respiratory Society M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Respiratory Society

What does European Respiratory Society do?

ERS is a professional medical society that delivers education, research dissemination, clinical guidelines, certification, and advocacy services to the global respiratory medicine community. Its core offerings include the annual ERS Congress, the ERS Respiratory Channel for online educational content, HERMES examinations for certification, clinical practice guidelines, peer-reviewed journals, fellowships, webinars, and training programmes, sold primarily through membership and event registration fees.

Is European Respiratory Society a public or private company?

European Respiratory Society is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was European Respiratory Society founded?

European Respiratory Society was founded in 1990. It employs 11 to 50 people.

Where is European Respiratory Society based?

European Respiratory Society is headquartered in Lausanne, Switzerland, in the Europe region.

How does European Respiratory Society make money?

Four revenue lines are on record. Membership Fees are the primary driver. The others are congress and Event Registration, webinar Fees for Non-Members and educational Programs.

Who are European Respiratory Society's main competitors?

Direct peers on record are American College of Chest Physicians (CHEST), American Thoracic Society (ATS), British Thoracic Society (BTS), Latin American Thoracic Association (ALAT) and Asian Pacific Society of Respirology (APSR). Emerging players are International Union Against Tuberculosis and Lung Disease (The Union) and European Sleep Research Society (ESRS). Broad incumbents are European Society for Medical Oncology (ESMO) and European Society of Cardiology (ESC). European Lung Foundation (ELF) is listed as an others.

Does European Respiratory Society have an API?

No public API is recorded for European Respiratory Society.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Today on MedscapeWhy Laughter May Be Good Medicine for COPDA clinical trial presented at the European Respiratory Society Congress found laughter therapy improved breathlessness and COPD symptoms as effectively as pursed-lip breathing. After 8 weeks, laughter therapy reduced Dyspnea-12 scores by 3.84 points versus 2.87 for pursed-lip breathing. The authors recommend it as a low-cost, equipment-free complementary tool for COPD patients.Today on MedscapeNew European Guidelines Update Pulmonary Hypertension CareThe European Respiratory Society updated its pulmonary arterial hypertension guidelines at the 2026 congress, incorporating sotatercept as a second-line treatment for patients at intermediate or high risk. The recommendation is based on high-certainty evidence from four randomized trials, while repeat right heart catheterization is advised only when likely to change management.FinancialContent Business PageU.S. FDA Approves Update to the Label for WINREVAIR™ (sotatercept-csrk) to Include Data from the Phase 3 HYPERION Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension (PAH,Merck announced FDA approval of a WINREVAIR label update based on the HYPERION trial, which showed adding WINREVAIR to background therapy reduced clinical worsening events by 76% in adults with PAH diagnosed within 12 months. The update also includes safety data, and the European Respiratory Society guidelines now recommend WINREVAIR strongly.Tom's GuideStudy says chatbots are misdiagnosing sleep apnea, so a doctor is sharing 4 symptoms you should never ignoreA study at the European Respiratory Society Congress found AI chatbots wrongly reassure sleep apnea patients in up to a third of cases. The research showed chatbots offered lifestyle changes instead of specialist referrals when patients downplayed symptoms. Dr. Weiss urges patients to seek medical advice for persistent symptoms.NaturalNewsBlogsMicroplastics found in lungs linked to lung cancer, new research shows – NaturalNews.comA study presented at the European Respiratory Society meeting found microplastics in 66% of lung cancer patients' lung fluid samples, compared to 46% of cancer-free patients. Lung cancer patients had twice the burden of microplastic particles, with polypropylene and polyethylene most common. Researchers caution that causation remains unproven.BeckershospitalreviewLung transplants in older adults grew 13-fold: 6 notesA study presented at the European Respiratory Society Congress 2026 found lung transplant recipients aged 70 and older rose 13-fold from 1% in 2004 to 13% worldwide. The median age of first evaluation rose 12 years over 15 years, driven by loss of young patients with cystic fibrosis and pulmonary hypertension. The national median recipient age is projected to reach 65 within one to two years.SciencedailyOzempic and Wegovy linked to nearly 40% fewer asthma attacksSemaglutide, used for type 2 diabetes and weight loss, was linked to nearly 40% fewer asthma attacks, according to new research presented at the European Respiratory Society Congress in Barcelona. The finding suggests an unexpected lung benefit for asthma patients.PR NewswireAltesa BioSciences Presents Novel Clinical Data Demonstrating Vapendavir Significantly Reduces Key Inflammatory Biomarkers in Rhinovirus-Challenged COPD Patients at the European Respiratory Society InAltesa BioSciences presented new clinical data at the ERS Congress showing vapendavir significantly reduced inflammatory biomarkers IP-10 and GM-CSF in rhinovirus-challenged COPD patients. The findings support a mechanistic link between the drug's antiviral activity and reduced airway inflammation, and the company is progressing to the Phase 2B CARDINAL study.New York PostSmoking is making you lonely: studyA study presented at the European Respiratory Society Congress found smokers are lonelier than non-smokers, with loneliness increasing over time. The research analyzed data from over 50,000 European participants, and experts say the findings could help motivate smokers to quit.Mirage NewsClassroom Dust Bacteria Linked to Kids' Lung IssuesA study presented at the European Respiratory Society Congress found that classroom dust containing Streptomyces and Mycobacterium bacteria is linked to reduced lung function in children. Children in classrooms with higher levels of these bacteria showed lower forced vital capacity and peak expiratory flow. The researchers suggest that improving indoor air quality, ventilation, and building maintenance could help prevent future lung disease.